Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.39 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.38 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7528799 | 0.89 | GAA (0.42) | ATMALDH1A1CYP2A6TSHRHSD17B10 | |
| SCHEMBL1402331 | 0.84 | CYP2A6 (0.44) | ATMALDH1A1CYP2A6TSHRHSD17B10 | |
| SCHEMBL5252480 | 0.78 | TSHR (0.52) | ATMALDH1A1CYP2A6TSHRHSD17B10 | |
| SCHEMBL774762 | 0.78 | KDM4E (0.50) | ATMALDH1A1CYP2A6TSHRHSD17B10 | |
| SCHEMBL8613108 | 0.77 | ATM (0.49) | ATMALDH1A1CYP2A6TSHRHSD17B10 | |
| SCHEMBL5252476 | 0.77 | ATM (0.45) | ATMALDH1A1CYP2A6TSHRHSD17B10 | |
| SCHEMBL6243050 | 0.77 | — | — | |
| SCHEMBL3568359 | 0.77 | ATM (0.49) | ATMALDH1A1CYP2A6TSHRHSD17B10 | |
| SCHEMBL11018809 | 0.77 | KDM4E (0.48) | ATMALDH1A1CYP2A6TSHRHSD17B10 | |
| SCHEMBL11018806 | 0.77 | KDM4E (0.48) | ATMALDH1A1CYP2A6TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113711113-B | Optical material, polymerizable composition for optical material, plastic lens, goggles, infrared sensor, and infrared camera | 三井化学株式会社 | 2023-07-28 | — | — | CN | disclosed |
| CN-113711113-A | Optical material, polymerizable composition for optical material, plastic lens, eyewear, infrared sensor, and infrared camera | 三井化学株式会社 | 2021-11-26 | — | — | CN | disclosed |
| WO-2020218614-A1 | OPTICAL MATERIAL, POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, PLASTIC LENS, EYEWEAR, INFRARED SENSOR, AND INFRARED CAMERA | 三井化学株式会社 | 2020-10-29 | — | — | WO | disclosed |
| US-7199139-B2 | Medicinal compositions containing diuretic and insulin resistance-improving agent | SANKYO COMPANY, LIMITED (JP) | 2007-04-03 | — | — | US | disclosed |
| EP-1354602-B1 | MEDICINAL COMPOSITIONS CONTAINING DIURETIC AND INSULIN RESISTANCE-IMPROVING AGENT | SANKYO CO (JP) | 2006-10-04 | — | — | EP | disclosed |
| EP-1695716-A2 | Medicinal compositions containing diuretics and insulin sensitizers | Sankyo Company, Limited (JP) | 2006-08-30 | — | — | EP | disclosed |
| US-20050288339-A1 | Medicinal compositions containing diuretic and insulin resistance-improving agent | SANKYO COMPANY, LIMITED (JP) | 2005-12-29 | — | — | US | disclosed |
| US-20040053974-A1 | Medicinal compositions containing diuretic and insulin resistance-improving agent | SANKYO COMPANY, LIMITED (JP) | 2004-03-18 | — | — | US | disclosed |
| US-20040006141-A1 | Amidocarboxylic acid compounds | SANKYO COMPANY, LTD (JP) | 2004-01-08 | — | — | US | disclosed |
| EP-1354602-A1 | MEDICINAL COMPOSITIONS CONTAINING DIURETIC AND INSULIN RESISTANCE-IMPROVING AGENT | Sankyo Company, Limited (JP) | 2003-10-22 | — | — | EP | disclosed |
| US-6528525-B1 | Amidocarboxylic acid derivatives | SANKYO COMPANY, LIMITED (JP) | 2003-03-04 | — | — | US | disclosed |
| EP-0928816-B1 | Phthalocyanine compound, its intermediate, process for producing the compound, and use thereof | YAMAMOTO CHEMICALS INC (JP) | 2002-03-06 | — | — | EP | disclosed |
| EP-1026149-A1 | AMIDOCARBOXYLIC ACID DERIVATIVES | Sankyo Company Limited (JP) | 2000-08-09 | — | — | EP | disclosed |
| US-6093832-A | NEAR INFRARED RAY ABSORBING MATERIAL OR A LIGHT-HEAT CONVERSION MATERIAL | YAMAMOTO CHEMICALS, INC. (JP) | 2000-07-25 | — | — | US | disclosed |
| US-5973140-A | Phthalocyanine compound, its intermediate, process for producing the compound, and use thereof | YAMAMOTO CHEMICALS, INC (JP) | 1999-10-26 | — | — | US | disclosed |
| EP-0928816-A2 | Phthalocyanine compound, its intermediate, process for producing the compound, and use thereof | Yamamoto Chemicals, Inc. (JP) | 1999-07-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040053974-A1 | Medicinal compositions containing diuretic and insulin resistance-improving agent | GPR119, INSR, IRS1 | ATM 1844/4885ALDH1A1 2128/4885CYP2A6 3649/4885 |
| US-20040006141-A1 | Amidocarboxylic acid compounds | NR1H2, AGK, APOL1 | ATM 311/4885ALDH1A1 3508/4885CYP2A6 769/4885 |
| US-20050288339-A1 | Medicinal compositions containing diuretic and insulin resistance-improving agent | GPR119, INSR, IRS1 | ATM 1844/4885ALDH1A1 2128/4885CYP2A6 3649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.